Rapid and Definitive Identification of Cyclic Peptide Soft Spots by Isotope-Labeled Reductive Dimethylation and Mass Spectrometry Fragmentation
Analytical Chemistry · 14.05.2024 · 96 (19) · 7756-7762
DOI: 10.1021/acs.analchem.4c01372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 01.05.2024. Verfasst von Yu Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nonclinical Drug Safety, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States. Hauptthemen laut MEDLINE: Peptides, Cyclic, Isotope Labeling. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Cyclic peptides are an emerging therapeutic modality over the past few decades. To identify drug candidates with sufficient proteolytic stability for oral administration, it is critical to pinpoint the amide bond hydrolysis sites, or soft spots, to better understand their metabolism and provide guidance on further structure optimization. However, the unambiguous characterization of cyclic peptide soft spots remains a significant challenge during early stage discovery studies, as amide bond hydrolysis forms a linearized isobaric sequence with the addition of a water molecule, regardless of the amide hydrolysis location. In this study, an innovative strategy was developed to enable the rapid and definitive identification of cyclic peptide soft spots by isotope-labeled reductive dimethylation and mass spectrometry fragmentation. The dimethylated immonium ion with enhanced MS signal at a distinctive m/z in MS/MS fragmentation spectra reveals the N-terminal amino acid on a linearized peptide sequence definitively and, thus, significantly simplifies the soft spot identification workflow. This approach has been evaluated to demonstrate the potential of isotope-labeled dimethylation to be a powerful analytical tool in cyclic peptide drug discovery and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nonclinical Drug Safety, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.
- Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.
ORCID-Profile: Yu Feng
Zitieren
APA
Feng, Y., Qirjollari, A., Fawaz, M. V., Cancilla, M. T., Gonzalez, R. J., & Pearson, K. (2024). Rapid and Definitive Identification of Cyclic Peptide Soft Spots by Isotope-Labeled Reductive Dimethylation and Mass Spectrometry Fragmentation. Analytical Chemistry, 96(19), 7756-7762. https://doi.org/10.1021/acs.analchem.4c01372
Vancouver
Feng Y, Qirjollari A, Fawaz MV, Cancilla MT, Gonzalez RJ, Pearson K. Rapid and Definitive Identification of Cyclic Peptide Soft Spots by Isotope-Labeled Reductive Dimethylation and Mass Spectrometry Fragmentation. Analytical Chemistry. 2024;96(19):7756-7762. doi:10.1021/acs.analchem.4c01372
BibTeX
@article{Feng2024,
author = {Feng, Yu and Qirjollari, Athanasia and Fawaz, Maria V and Cancilla, Mark T and Gonzalez, Raymond J and Pearson, Kara},
title = {Rapid and Definitive Identification of Cyclic Peptide Soft Spots by Isotope-Labeled Reductive Dimethylation and Mass Spectrometry Fragmentation},
journal = {Analytical Chemistry},
year = {2024},
volume = {96},
number = {19},
pages = {7756--7762},
doi = {10.1021/acs.analchem.4c01372}
}
EUVIMED